Hemostasis Diagnostics Market Size, Share & Trends Analysis Report By Product (Laboratory Analyzers), By Test (Activated Partial Thromboplastin Time, D-Dimer Test, Fibrinogen Test, Prothrombin Time (PT) Test, Other Tests), By End User (Hospitals, Diagnostic Laboratories, Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: December 10, 2025 | Author: Debashree B | Format: | Report Code: SR7508DR | Pages: 110

Market Segmentation

  1. Hemostasis Diagnostics Market, By Product 2022-2034 (USD MILLION/ Units)
    1. Laboratory Analyzers
      1. Automated Systems
      2. Semi-automated Systems
      3. Manual Systems
      4. Point-of-Care Testing Systems
      5. Reagents & Consumables
  2. Hemostasis Diagnostics Market, By Test 2022-2034 (USD MILLION/ Units)
    1. Activated Partial Thromboplastin Time
    2. D-Dimer Test
    3. Fibrinogen Test
    4. Prothrombin Time (PT) Test
    5. Other Tests
  3. Hemostasis Diagnostics Market, By End User 2022-2034 (USD MILLION/ Units)
    1. Hospitals
    2. Diagnostic Laboratories
    3. Others
  4. Regional Hemostasis Diagnostics Market
    1. North America
      1. North America Hemostasis Diagnostics Market By Product 2022-2034 (USD MILLION/ Units)
        1. Laboratory Analyzers
          1. Automated Systems
          2. Semi-automated Systems
          3. Manual Systems
          4. Point-of-Care Testing Systems
          5. Reagents & Consumables
      2. North America Hemostasis Diagnostics Market By Test 2022-2034 (USD MILLION/ Units)
        1. Activated Partial Thromboplastin Time
        2. D-Dimer Test
        3. Fibrinogen Test
        4. Prothrombin Time (PT) Test
        5. Other Tests
      3. North America Hemostasis Diagnostics Market By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Laboratories
        3. Others
      4. U.S.
        1. Laboratory Analyzers
          1. Automated Systems
          2. Semi-automated Systems
          3. Manual Systems
          4. Point-of-Care Testing Systems
          5. Reagents & Consumables
        2. Activated Partial Thromboplastin Time
        3. D-Dimer Test
        4. Fibrinogen Test
        5. Prothrombin Time (PT) Test
        6. Other Tests
        7. Hospitals
        8. Diagnostic Laboratories
        9. Others
      5. Canada
        1. Laboratory Analyzers
          1. Automated Systems
          2. Semi-automated Systems
          3. Manual Systems
          4. Point-of-Care Testing Systems
          5. Reagents & Consumables
        2. Activated Partial Thromboplastin Time
        3. D-Dimer Test
        4. Fibrinogen Test
        5. Prothrombin Time (PT) Test
        6. Other Tests
        7. Hospitals
        8. Diagnostic Laboratories
        9. Others
    2. Europe
      1. Europe Hemostasis Diagnostics Market By Product 2022-2034 (USD MILLION/ Units)
        1. Laboratory Analyzers
          1. Automated Systems
          2. Semi-automated Systems
          3. Manual Systems
          4. Point-of-Care Testing Systems
          5. Reagents & Consumables
      2. Europe Hemostasis Diagnostics Market By Test 2022-2034 (USD MILLION/ Units)
        1. Activated Partial Thromboplastin Time
        2. D-Dimer Test
        3. Fibrinogen Test
        4. Prothrombin Time (PT) Test
        5. Other Tests
      3. Europe Hemostasis Diagnostics Market By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Laboratories
        3. Others
      4. U.K.
        1. Laboratory Analyzers
          1. Automated Systems
          2. Semi-automated Systems
          3. Manual Systems
          4. Point-of-Care Testing Systems
          5. Reagents & Consumables
        2. Activated Partial Thromboplastin Time
        3. D-Dimer Test
        4. Fibrinogen Test
        5. Prothrombin Time (PT) Test
        6. Other Tests
        7. Hospitals
        8. Diagnostic Laboratories
        9. Others
      5. Germany
        1. Laboratory Analyzers
          1. Automated Systems
          2. Semi-automated Systems
          3. Manual Systems
          4. Point-of-Care Testing Systems
          5. Reagents & Consumables
        2. Activated Partial Thromboplastin Time
        3. D-Dimer Test
        4. Fibrinogen Test
        5. Prothrombin Time (PT) Test
        6. Other Tests
        7. Hospitals
        8. Diagnostic Laboratories
        9. Others
      6. France
        1. Laboratory Analyzers
          1. Automated Systems
          2. Semi-automated Systems
          3. Manual Systems
          4. Point-of-Care Testing Systems
          5. Reagents & Consumables
        2. Activated Partial Thromboplastin Time
        3. D-Dimer Test
        4. Fibrinogen Test
        5. Prothrombin Time (PT) Test
        6. Other Tests
        7. Hospitals
        8. Diagnostic Laboratories
        9. Others
      7. Spain
        1. Laboratory Analyzers
          1. Automated Systems
          2. Semi-automated Systems
          3. Manual Systems
          4. Point-of-Care Testing Systems
          5. Reagents & Consumables
        2. Activated Partial Thromboplastin Time
        3. D-Dimer Test
        4. Fibrinogen Test
        5. Prothrombin Time (PT) Test
        6. Other Tests
        7. Hospitals
        8. Diagnostic Laboratories
        9. Others
      8. Italy
        1. Laboratory Analyzers
          1. Automated Systems
          2. Semi-automated Systems
          3. Manual Systems
          4. Point-of-Care Testing Systems
          5. Reagents & Consumables
        2. Activated Partial Thromboplastin Time
        3. D-Dimer Test
        4. Fibrinogen Test
        5. Prothrombin Time (PT) Test
        6. Other Tests
        7. Hospitals
        8. Diagnostic Laboratories
        9. Others
      9. Russia
        1. Laboratory Analyzers
          1. Automated Systems
          2. Semi-automated Systems
          3. Manual Systems
          4. Point-of-Care Testing Systems
          5. Reagents & Consumables
        2. Activated Partial Thromboplastin Time
        3. D-Dimer Test
        4. Fibrinogen Test
        5. Prothrombin Time (PT) Test
        6. Other Tests
        7. Hospitals
        8. Diagnostic Laboratories
        9. Others
      10. Nordic
        1. Laboratory Analyzers
          1. Automated Systems
          2. Semi-automated Systems
          3. Manual Systems
          4. Point-of-Care Testing Systems
          5. Reagents & Consumables
        2. Activated Partial Thromboplastin Time
        3. D-Dimer Test
        4. Fibrinogen Test
        5. Prothrombin Time (PT) Test
        6. Other Tests
        7. Hospitals
        8. Diagnostic Laboratories
        9. Others
      11. Benelux
        1. Laboratory Analyzers
          1. Automated Systems
          2. Semi-automated Systems
          3. Manual Systems
          4. Point-of-Care Testing Systems
          5. Reagents & Consumables
        2. Activated Partial Thromboplastin Time
        3. D-Dimer Test
        4. Fibrinogen Test
        5. Prothrombin Time (PT) Test
        6. Other Tests
        7. Hospitals
        8. Diagnostic Laboratories
        9. Others
      12. Rest of Europe
        1. Laboratory Analyzers
          1. Automated Systems
          2. Semi-automated Systems
          3. Manual Systems
          4. Point-of-Care Testing Systems
          5. Reagents & Consumables
        2. Activated Partial Thromboplastin Time
        3. D-Dimer Test
        4. Fibrinogen Test
        5. Prothrombin Time (PT) Test
        6. Other Tests
        7. Hospitals
        8. Diagnostic Laboratories
        9. Others
    3. APAC
      1. APAC Hemostasis Diagnostics Market By Product 2022-2034 (USD MILLION/ Units)
        1. Laboratory Analyzers
          1. Automated Systems
          2. Semi-automated Systems
          3. Manual Systems
          4. Point-of-Care Testing Systems
          5. Reagents & Consumables
      2. APAC Hemostasis Diagnostics Market By Test 2022-2034 (USD MILLION/ Units)
        1. Activated Partial Thromboplastin Time
        2. D-Dimer Test
        3. Fibrinogen Test
        4. Prothrombin Time (PT) Test
        5. Other Tests
      3. APAC Hemostasis Diagnostics Market By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Laboratories
        3. Others
      4. China
        1. Laboratory Analyzers
          1. Automated Systems
          2. Semi-automated Systems
          3. Manual Systems
          4. Point-of-Care Testing Systems
          5. Reagents & Consumables
        2. Activated Partial Thromboplastin Time
        3. D-Dimer Test
        4. Fibrinogen Test
        5. Prothrombin Time (PT) Test
        6. Other Tests
        7. Hospitals
        8. Diagnostic Laboratories
        9. Others
      5. Korea
        1. Laboratory Analyzers
          1. Automated Systems
          2. Semi-automated Systems
          3. Manual Systems
          4. Point-of-Care Testing Systems
          5. Reagents & Consumables
        2. Activated Partial Thromboplastin Time
        3. D-Dimer Test
        4. Fibrinogen Test
        5. Prothrombin Time (PT) Test
        6. Other Tests
        7. Hospitals
        8. Diagnostic Laboratories
        9. Others
      6. Japan
        1. Laboratory Analyzers
          1. Automated Systems
          2. Semi-automated Systems
          3. Manual Systems
          4. Point-of-Care Testing Systems
          5. Reagents & Consumables
        2. Activated Partial Thromboplastin Time
        3. D-Dimer Test
        4. Fibrinogen Test
        5. Prothrombin Time (PT) Test
        6. Other Tests
        7. Hospitals
        8. Diagnostic Laboratories
        9. Others
      7. India
        1. Laboratory Analyzers
          1. Automated Systems
          2. Semi-automated Systems
          3. Manual Systems
          4. Point-of-Care Testing Systems
          5. Reagents & Consumables
        2. Activated Partial Thromboplastin Time
        3. D-Dimer Test
        4. Fibrinogen Test
        5. Prothrombin Time (PT) Test
        6. Other Tests
        7. Hospitals
        8. Diagnostic Laboratories
        9. Others
      8. Australia
        1. Laboratory Analyzers
          1. Automated Systems
          2. Semi-automated Systems
          3. Manual Systems
          4. Point-of-Care Testing Systems
          5. Reagents & Consumables
        2. Activated Partial Thromboplastin Time
        3. D-Dimer Test
        4. Fibrinogen Test
        5. Prothrombin Time (PT) Test
        6. Other Tests
        7. Hospitals
        8. Diagnostic Laboratories
        9. Others
      9. Taiwan
        1. Laboratory Analyzers
          1. Automated Systems
          2. Semi-automated Systems
          3. Manual Systems
          4. Point-of-Care Testing Systems
          5. Reagents & Consumables
        2. Activated Partial Thromboplastin Time
        3. D-Dimer Test
        4. Fibrinogen Test
        5. Prothrombin Time (PT) Test
        6. Other Tests
        7. Hospitals
        8. Diagnostic Laboratories
        9. Others
      10. South East Asia
        1. Laboratory Analyzers
          1. Automated Systems
          2. Semi-automated Systems
          3. Manual Systems
          4. Point-of-Care Testing Systems
          5. Reagents & Consumables
        2. Activated Partial Thromboplastin Time
        3. D-Dimer Test
        4. Fibrinogen Test
        5. Prothrombin Time (PT) Test
        6. Other Tests
        7. Hospitals
        8. Diagnostic Laboratories
        9. Others
      11. Rest of Asia-Pacific
        1. Laboratory Analyzers
          1. Automated Systems
          2. Semi-automated Systems
          3. Manual Systems
          4. Point-of-Care Testing Systems
          5. Reagents & Consumables
        2. Activated Partial Thromboplastin Time
        3. D-Dimer Test
        4. Fibrinogen Test
        5. Prothrombin Time (PT) Test
        6. Other Tests
        7. Hospitals
        8. Diagnostic Laboratories
        9. Others
    4. Middle East and Africa
      1. Middle East and Africa Hemostasis Diagnostics Market By Product 2022-2034 (USD MILLION/ Units)
        1. Laboratory Analyzers
          1. Automated Systems
          2. Semi-automated Systems
          3. Manual Systems
          4. Point-of-Care Testing Systems
          5. Reagents & Consumables
      2. Middle East and Africa Hemostasis Diagnostics Market By Test 2022-2034 (USD MILLION/ Units)
        1. Activated Partial Thromboplastin Time
        2. D-Dimer Test
        3. Fibrinogen Test
        4. Prothrombin Time (PT) Test
        5. Other Tests
      3. Middle East and Africa Hemostasis Diagnostics Market By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Laboratories
        3. Others
      4. UAE
        1. Laboratory Analyzers
          1. Automated Systems
          2. Semi-automated Systems
          3. Manual Systems
          4. Point-of-Care Testing Systems
          5. Reagents & Consumables
        2. Activated Partial Thromboplastin Time
        3. D-Dimer Test
        4. Fibrinogen Test
        5. Prothrombin Time (PT) Test
        6. Other Tests
        7. Hospitals
        8. Diagnostic Laboratories
        9. Others
      5. Turkey
        1. Laboratory Analyzers
          1. Automated Systems
          2. Semi-automated Systems
          3. Manual Systems
          4. Point-of-Care Testing Systems
          5. Reagents & Consumables
        2. Activated Partial Thromboplastin Time
        3. D-Dimer Test
        4. Fibrinogen Test
        5. Prothrombin Time (PT) Test
        6. Other Tests
        7. Hospitals
        8. Diagnostic Laboratories
        9. Others
      6. Saudi Arabia
        1. Laboratory Analyzers
          1. Automated Systems
          2. Semi-automated Systems
          3. Manual Systems
          4. Point-of-Care Testing Systems
          5. Reagents & Consumables
        2. Activated Partial Thromboplastin Time
        3. D-Dimer Test
        4. Fibrinogen Test
        5. Prothrombin Time (PT) Test
        6. Other Tests
        7. Hospitals
        8. Diagnostic Laboratories
        9. Others
      7. South Africa
        1. Laboratory Analyzers
          1. Automated Systems
          2. Semi-automated Systems
          3. Manual Systems
          4. Point-of-Care Testing Systems
          5. Reagents & Consumables
        2. Activated Partial Thromboplastin Time
        3. D-Dimer Test
        4. Fibrinogen Test
        5. Prothrombin Time (PT) Test
        6. Other Tests
        7. Hospitals
        8. Diagnostic Laboratories
        9. Others
      8. Egypt
        1. Laboratory Analyzers
          1. Automated Systems
          2. Semi-automated Systems
          3. Manual Systems
          4. Point-of-Care Testing Systems
          5. Reagents & Consumables
        2. Activated Partial Thromboplastin Time
        3. D-Dimer Test
        4. Fibrinogen Test
        5. Prothrombin Time (PT) Test
        6. Other Tests
        7. Hospitals
        8. Diagnostic Laboratories
        9. Others
      9. Nigeria
        1. Laboratory Analyzers
          1. Automated Systems
          2. Semi-automated Systems
          3. Manual Systems
          4. Point-of-Care Testing Systems
          5. Reagents & Consumables
        2. Activated Partial Thromboplastin Time
        3. D-Dimer Test
        4. Fibrinogen Test
        5. Prothrombin Time (PT) Test
        6. Other Tests
        7. Hospitals
        8. Diagnostic Laboratories
        9. Others
      10. Rest of MEA
        1. Laboratory Analyzers
          1. Automated Systems
          2. Semi-automated Systems
          3. Manual Systems
          4. Point-of-Care Testing Systems
          5. Reagents & Consumables
        2. Activated Partial Thromboplastin Time
        3. D-Dimer Test
        4. Fibrinogen Test
        5. Prothrombin Time (PT) Test
        6. Other Tests
        7. Hospitals
        8. Diagnostic Laboratories
        9. Others
    5. LATAM
      1. LATAM Hemostasis Diagnostics Market By Product 2022-2034 (USD MILLION/ Units)
        1. Laboratory Analyzers
          1. Automated Systems
          2. Semi-automated Systems
          3. Manual Systems
          4. Point-of-Care Testing Systems
          5. Reagents & Consumables
      2. LATAM Hemostasis Diagnostics Market By Test 2022-2034 (USD MILLION/ Units)
        1. Activated Partial Thromboplastin Time
        2. D-Dimer Test
        3. Fibrinogen Test
        4. Prothrombin Time (PT) Test
        5. Other Tests
      3. LATAM Hemostasis Diagnostics Market By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Laboratories
        3. Others
      4. Brazil
        1. Laboratory Analyzers
          1. Automated Systems
          2. Semi-automated Systems
          3. Manual Systems
          4. Point-of-Care Testing Systems
          5. Reagents & Consumables
        2. Activated Partial Thromboplastin Time
        3. D-Dimer Test
        4. Fibrinogen Test
        5. Prothrombin Time (PT) Test
        6. Other Tests
        7. Hospitals
        8. Diagnostic Laboratories
        9. Others
      5. Mexico
        1. Laboratory Analyzers
          1. Automated Systems
          2. Semi-automated Systems
          3. Manual Systems
          4. Point-of-Care Testing Systems
          5. Reagents & Consumables
        2. Activated Partial Thromboplastin Time
        3. D-Dimer Test
        4. Fibrinogen Test
        5. Prothrombin Time (PT) Test
        6. Other Tests
        7. Hospitals
        8. Diagnostic Laboratories
        9. Others
      6. Argentina
        1. Laboratory Analyzers
          1. Automated Systems
          2. Semi-automated Systems
          3. Manual Systems
          4. Point-of-Care Testing Systems
          5. Reagents & Consumables
        2. Activated Partial Thromboplastin Time
        3. D-Dimer Test
        4. Fibrinogen Test
        5. Prothrombin Time (PT) Test
        6. Other Tests
        7. Hospitals
        8. Diagnostic Laboratories
        9. Others
      7. Chile
        1. Laboratory Analyzers
          1. Automated Systems
          2. Semi-automated Systems
          3. Manual Systems
          4. Point-of-Care Testing Systems
          5. Reagents & Consumables
        2. Activated Partial Thromboplastin Time
        3. D-Dimer Test
        4. Fibrinogen Test
        5. Prothrombin Time (PT) Test
        6. Other Tests
        7. Hospitals
        8. Diagnostic Laboratories
        9. Others
      8. Colombia
        1. Laboratory Analyzers
          1. Automated Systems
          2. Semi-automated Systems
          3. Manual Systems
          4. Point-of-Care Testing Systems
          5. Reagents & Consumables
        2. Activated Partial Thromboplastin Time
        3. D-Dimer Test
        4. Fibrinogen Test
        5. Prothrombin Time (PT) Test
        6. Other Tests
        7. Hospitals
        8. Diagnostic Laboratories
        9. Others
      9. Rest of LATAM
        1. Laboratory Analyzers
          1. Automated Systems
          2. Semi-automated Systems
          3. Manual Systems
          4. Point-of-Care Testing Systems
          5. Reagents & Consumables
        2. Activated Partial Thromboplastin Time
        3. D-Dimer Test
        4. Fibrinogen Test
        5. Prothrombin Time (PT) Test
        6. Other Tests
        7. Hospitals
        8. Diagnostic Laboratories
        9. Others
Reach out to us
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on: